BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Reneo Pharmaceuticals is a clinical-stage start-up company, co-founded by Pappas Capital, focused on developing treatments for rare metabolic disorders
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.